Published in TB and Outbreaks Week, October 12th, 2004
The award covers early development of a vaccine against SARS (severe acute respiratory syndrome), a new infectious disease that first appeared in 2003 in Asia and spread rapidly to other parts of the world, infecting over 8000 people. In addition to proving highly infectious, SARS also incurred a high mortality rate, killing 10% of the people it infected.
Although ultimately checked...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.